- Home
- CADL vs MPAA Comparison
CADL vs MPAA Comparison
Compare CADL & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- MPAA
- Stock Information
- Founded
- CADL 1999
- MPAA 1968
- Country
- CADL United States
- MPAA United States
- Employees
- CADL N/A
- MPAA N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- MPAA Auto Parts:O.E.M.
- Sector
- CADL Health Care
- MPAA Consumer Discretionary
- Exchange
- CADL Nasdaq
- MPAA Nasdaq
- Market Cap
- CADL 313.5M
- MPAA 281.2M
- IPO Year
- CADL 2021
- MPAA 1994
- Fundamental
- Price
- CADL $4.84
- MPAA $16.00
- Analyst Decision
- CADL Strong Buy
- MPAA
- Analyst Count
- CADL 5
- MPAA 0
- Target Price
- CADL $19.80
- MPAA N/A
- AVG Volume (30 Days)
- CADL 697.1K
- MPAA 163.1K
- Earning Date
- CADL 11-13-2025
- MPAA 11-11-2025
- Dividend Yield
- CADL N/A
- MPAA N/A
- EPS Growth
- CADL N/A
- MPAA N/A
- EPS
- CADL N/A
- MPAA 0.08
- Revenue
- CADL N/A
- MPAA $775,831,000.00
- Revenue This Year
- CADL N/A
- MPAA $10.44
- Revenue Next Year
- CADL N/A
- MPAA $4.88
- P/E Ratio
- CADL N/A
- MPAA $200.82
- Revenue Growth
- CADL N/A
- MPAA 6.59
- 52 Week Low
- CADL $3.79
- MPAA $5.16
- 52 Week High
- CADL $14.60
- MPAA $16.59
- Technical
- Relative Strength Index (RSI)
- CADL 34.62
- MPAA 66.82
- Support Level
- CADL $4.60
- MPAA $15.55
- Resistance Level
- CADL $5.01
- MPAA $16.30
- Average True Range (ATR)
- CADL 0.29
- MPAA 0.60
- MACD
- CADL -0.04
- MPAA 0.05
- Stochastic Oscillator
- CADL 15.28
- MPAA 75.21
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.